Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2010
05/05/2010CN1446261B Modified cytokines for use in cancer therapy
05/05/2010CN101702906A Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
05/05/2010CN101701039A Variable regions of light chains and heavy chains of FMU-EPCAM-2A9 monoclonal antibodies
05/05/2010CN101701033A Methods for preparing antigen, antibody and sample of Eperythrozoon suis
05/04/2010US7709618 BTL-II nucleic acids
05/04/2010US7709615 Polynucleotides encoding anti-ganglioside antibodies
05/04/2010US7709611 antibodies and antigen binding domains and CDR regions that mediate selective binding to an epitope located in the carboxyl half of the Dkk-1 protein; for bone disorders, inflammatory, neurological, ocular, renal, pulmonary and skin diseases
05/04/2010US7709610 As an antagonist that inhibits immunoglobulin secretion; autoimmune disorders; antiproliferative , anticarcinogenic and antiarthritic agents; inflammatory bowel disease
05/04/2010US7709607 solubility of the variant is improved by at least 3-fold relative to residues 110-244 of human adiponectin; increased soluble expression and stability, lower immunogenicity, and improved pharmacokinetics and/or pharmacodynamics
05/04/2010US7709603 PRO1190 polypeptides
05/04/2010US7709451 Method and composition for treating immune complex associated disorders
05/04/2010US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders
05/04/2010US7709252 Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
05/04/2010US7709226 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences; converting an antibody sequence of any subject species to a less immunogenic form
05/04/2010US7709224 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
05/04/2010US7709220 Methods of monitoring treatment of BAFF-R related disease
05/04/2010US7709219 Compositions and methods for detection of antibody binding to cells
05/04/2010US7709218 Tumor necrosis factor receptors 6α and 6β
05/04/2010US7709217 Mixture comprising hemopoietic cytokine specific immunnoglobulin for use in detection of infection and immunololgical disorders
05/04/2010US7709209 Protein ligands
05/04/2010US7709009 Immunogenic compositions for streptococcus pyogenes
05/04/2010US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes
05/04/2010US7709006 Hepatitis-C virus testing
05/04/2010US7709000 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells
05/04/2010US7708999 Inhibiting activity of fibroblast growth factor 8; preventing joint destruction, protecting cartilage, inhibiting growth of synovial membrane; diagnostic agent; antibody active ingredient
05/04/2010US7708998 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
05/04/2010US7708997 antibody composition comprising a Fc region with complex N-glycoside-linked sugar chains bound to the Fc region through N-acetylglucosamines of the reducing terminal of the sugar chains
05/04/2010US7708996 Tumor necrosis factor receptor specific immunoglobulins for use in treatment and prevention of cancers, autoimmune, viral, inflammatory, graft vs host and nervous system disorders
05/04/2010US7708995 Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
05/04/2010US7708994 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor
05/04/2010US7708992 Methods for producing antibody compositions with increased ADCC
05/04/2010US7708991 Method for treating cancer and identifying novel anti-cancer compounds
05/04/2010US7708984 Using immunoglobulin specific to adenoid expressed chemokine (ADEC) for prevention and treatment of cell proliferative, glandular and viral infection
05/04/2010CA2412880C Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product
05/04/2010CA2335364C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
05/04/2010CA2319057C Compositions comprising a poly(oxyethylene)-poly(oxypropylene) block copolymer and their use
05/04/2010CA2299624C Mammalian cytokine receptor - 11
05/04/2010CA2140638C Generation of xenogeneic antibodies
04/2010
04/29/2010WO2010048615A2 Human ebola virus species and compositions and methods thereof
04/29/2010WO2010048588A2 Directed engagement of activating fc receptors
04/29/2010WO2010048520A1 Lipidated imidazoquinoline derivatives
04/29/2010WO2010048313A2 Recombinant fcrn and variants thereof for purification of fc-containing fusion proteins
04/29/2010WO2010048304A2 Identification of signature genes associated with hepatocellular carcinoma
04/29/2010WO2010048192A2 Viral inactivation during purification of antibodies
04/29/2010WO2010048190A2 Antibodies that bind to il-12 and methods of purifying the same
04/29/2010WO2010048183A1 Antibodies that bind to il-18 and methods of purifying the same
04/29/2010WO2010048026A2 Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment
04/29/2010WO2010047830A2 Agents for hcv treatment
04/29/2010WO2010047509A2 Anti-dr5 antibody with improved affinity and stability, and composition for cancer prevention or treatment including same
04/29/2010WO2010047310A1 Tumor antigen peptide and use thereof
04/29/2010WO2010047117A1 Novel monoclonal antibody and use thereof
04/29/2010WO2010046775A2 Methods for producing antibodies from plasma cells
04/29/2010WO2010046771A1 Immunization protocol for directed expansion and maturation
04/29/2010WO2010046592A2 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies
04/29/2010WO2010046337A2 Ligands that have binding specificity for dc-sign
04/29/2010WO2010046094A1 Determination of immunoglobulin encoding nucleid acid
04/29/2010WO2010024704A3 A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof
04/29/2010WO2010011947A3 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES
04/29/2010WO2010005570A3 Compositions comprising antibodies to lingo or fragments thereof
04/29/2010WO2010004276A3 Antibody
04/29/2010WO2010004204A3 Fgf-r4 receptor-specific antagonists
04/29/2010WO2009158658A3 Induction of flocculation in photosynthetic organisms
04/29/2010WO2009149382A3 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
04/29/2010WO2008146911A9 Antibody directed against il13ra2, and diagnostic/therapeutic agent comprising the antibody
04/29/2010US20100105877 An insulinotropic complex using an immunoglobulin fragment
04/29/2010US20100105876 Method for the oligomerisation of peptides
04/29/2010US20100105875 Antibodies against neisserial factor H binding protein
04/29/2010US20100105874 Bispecific antibodies and methods for production thereof
04/29/2010US20100105873 Integrated approach for generating multidomain protein therapeutics
04/29/2010US20100105869 Physiologically Active Polypeptide Conjugate Having Prolonged In Vivo Half-Life
04/29/2010US20100105865 Nucleic acids and proteins from streptococcus groups a & b
04/29/2010US20100105623 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs
04/29/2010US20100105599 Subtilisin variants
04/29/2010US20100105150 Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal
04/29/2010US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
04/29/2010US20100105090 Secreted luciferase mluc7 and use thereof
04/29/2010US20100105088 method for diagnosing atherosclerotic plaques by measurement of cd36
04/29/2010US20100105087 Biomarkers for breast cancer
04/29/2010US20100105068 Hybridomas producing antibodies against non functional p2x7 receptor
04/29/2010US20100105051 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
04/29/2010US20100104589 Immunoconjugates with an Intracellularly-Cleavable Linkage
04/29/2010US20100104588 Serum albumin binding peptides for tumor targeting
04/29/2010US20100104582 CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts
04/29/2010US20100104577 Methods and materials related to anti-a (beta) antibodies
04/29/2010US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization;
04/29/2010US20100104575 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
04/29/2010US20100104574 Frizzled-Binding Agents and Uses Thereof
04/29/2010US20100104573 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
04/29/2010US20100104572 Methods for screening for therapeutic molecules and use of the molecules therefrom
04/29/2010US20100104571 Antibody-mediated modulation of allergy
04/29/2010US20100104569 Humanized antibodies to interferon alpha receptor-1 (ifnar-1)
04/29/2010US20100104568 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
04/29/2010US20100104564 Altered Antibody Fc Regions and Uses Thereof
04/29/2010US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
04/29/2010US20100104560 Botulinum neurotoxin e receptors and uses thereof
04/29/2010US20100104557 Optimized Antibodies that Target HM1.24
04/29/2010US20100104556 Epitope-tag for surface-expressed proteins and uses thereof
04/29/2010US20100104555 HCV neutralizing epitopes
04/29/2010US20100104553 Antibodies and methods for making and using them
04/29/2010US20100104530 Anti-vpac1 antibodies and their uses
1 ... 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 ... 1494